|
Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG) |
|
|
|
Title: |
Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG) |
Author: |
Aamdal, S. Lund, B. Koier, I. Houten, M. Wanders, J. Verweij, J. |
Appeared in: |
Cancer, chemotherapy and pharmacology |
Paging: |
Volume 45 (2000) nr. 1 pages 85-88 |
Year: |
2000 |
Contents: |
|
Publisher: |
Springer-Verlag, Berlin/Heidelberg |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|